$156.6M in CY2024 Part D spend3.8M claims · 1.2M beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Hydroxychloroquine used for?
Hydroxychloroquine sulfate tablets are an antimalarial and antirheumatic indicated for the: Treatment of uncomplicated malaria due to Plasmodium falciparum, Plasmodium malariae, Plasmodium ovale, a....
Is there a generic for Hydroxychloroquine?
Yes. 19 ANDAs filed at FDA, 13 generic manufacturers currently shipping.
How much does my plan pay for Hydroxychloroquine?
Across 329 Part D plans, Hydroxychloroquine averages $0.164/unit (NADAC). Lowest available: $0.164/unit. Highest in distribution: $0.164/unit.
Is Hydroxychloroquine on the FDA shortage list?
Hydroxychloroquine has been discontinued by its manufacturer(s).
7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.